cobas t 511 coagulation analyzer and cobas t 711 coagulation analyzer

In vitro assay, with increased lupus sensitivity, for the determination of activated partial thromboplastin time (aPTT) in citrated plasma on the indicated cobas t analyzers. The aPTT is used to evaluate the intrinsic coagulation pathway.

In vitro assay for the determination of activated partial thromboplastin time (aPTT) in citrated plasma on the indicated cobas t analyzers. The aPTT is used to evaluate the intrinsic coagulation pathway.

In vitro assay, with reduced lupus sensitivity, for the determination of activated partial thromboplastin time (aPTT) in citrated plasma on the indicated cobas t analyzers. The aPTT is used to evaluate the intrinsic coagulation pathway.

In vitro assay for the quantitative determination of antithrombin activity in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the diagnosis of antithrombin deficiency.

In vitro assay for the quantitative immunological determination of fibrin degradation products (D‑dimer and X‑oligomers) in human citrated plasma on the indicated cobas t analyzers. In conjunction with a non-high clinical probability assessment, a normal D‑dimer result (< 0.5 μg FEUa)/mL) is intended as an aid in the exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE).

In vitro assay for the quantitative determination of fibrinogen (Clauss method) in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the detection of hypo- and hyperfibrinogenemia, dysfibrinogenemia and afibrinogenemia.

The derived fibrinogen result is intended as an aid in the diagnosis of a fibrinogen deficiency.

In vitro assay for the determination of the Owrens prothrombin time in citrated plasma on the indicated cobas t analyzers. The Owrens prothrombin time is intended as an aid in the management of vitamin K antagonist therapy.

In vitro assay for the determination of prothrombin time and derived fibrinogen in citrated plasma on the indicated cobas t analyzers. The prothrombin time is used for evaluation of the extrinsic coagulation pathway and as an aid in the management of vitamin K antagonist therapy. The derived fibrinogen result is intended as an aid in the diagnosis of a fibrinogen deficiency.

In vitro assay for the determination of Thrombin Time (TT) in human citrated plasma on the indicated cobas t analyzers.

In vitro assay for the quantitative determination of the anti-Xa activity of unfractionated (UFH) and low molecular weight (LMWH) heparins in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the management of anti-Xa Heparin therapy.

In vitro test for the semi-quantitative determination of the lipemia index, hemolysis index and icterus index in citrated plasma on cobas t systems.